Investing
Top Active Trader Alert Stocks (ALIM, APWR, MAIL, PSDV, TSLA)
Published:
Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Alimera Sciences Inc. (NASDAQ: ALIM), A-Power Energy Generation Systems, Ltd. (NASDAQ: APWR), IncrediMail Ltd. (NASDAQ: MAIL), pSivida Corp. (NASDAQ: PSDV), and Tesla Motors Inc. (NASDAQ: TSLA).
Alimera Sciences Inc. (NASDAQ: ALIM) received news this morning that the FDA had chosen not to approve the Iluvien drug it had produced with its partner. Shares of ALIM are down 20% to $9.00, relative to a 52-week range of $6.30-$12.70.
A-Power Energy Generation Systems, Ltd. (NASDAQ: APWR) is up more than 12% to $5.80, relative to a 52-week range of $4.55-$20.32. The company recently announced a new engineering, procurement, and construction contract.
IncrediMail Ltd. (NASDAQ: MAIL) just signed a new 2-year deal with Google (NASDAQ: GOOG) and is now up 7% premarket to $7.61, relative to a 52-week range of $3.85-$10.75.
pSivida Corp. (NASDAQ: PSDV) is also down on the Iluvien FDA newsShares of PSDV have plummeted nearly 28% to $4.60, relative to a 52-week range of $3.08-$7.22.
Tesla Motors Inc. (NASDAQ: TSLA) is down premarket from the holiday weekend after several downgrades to sell. Shares of TSLA are down 4.5% to $28.80, relative to a 52-week range of $14.98-$36.42.
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
